The Economic Burden and Main Drivers of Healthcare Resource Utilization in RSV

Focusing on the economic burden of RSV, the panel discusses financial considerations for multiple patient populations, highlighting hospitalization costs and the main drivers of healthcare resource utilization.

EP: 1.Overview of RSV Patient Populations

EP: 2.Complications Associated with RSV Infections

Now Viewing

EP: 3.The Economic Burden and Main Drivers of Healthcare Resource Utilization in RSV

EP: 4.RSV: Risk Factors and How It’s Spread

EP: 5.Diagnostic Practices for RSV

EP: 6.Increasing Awareness of RSV Vaccines in At-Risk Patients

EP: 7.Shared Decision-Making Practices in RSV

EP: 8.Financial and Clinical Benefits of RSV Immunization

EP: 9.The Potential Benefits of RSV Vaccine Approval for Adults Aged 50-59

EP: 10.Addressing Vaccine Fatigue

EP: 11.Identifying Patients Eligible for RSV Vaccine

EP: 12.Current and Potential Obstacles Related to Administering RSV Vaccines

EP: 13.Improving Insurance Coverage for RSV Vaccines

EP: 14.Improving RSV Vaccination Rates and Addressing Misinformation

EP: 15.Key Takeaways on RSV Vaccination

Video content above is prompted by the following questions:

• Please describe the economic burden of RSV, especially in adults aged 50-59 and those 60 and older.
• What are the main drivers of healthcare resource utilization in high-risk patients with RSV?
  

Related Videos

Related Content

Advertisement

May 14th 2025

Infant RSV Hospitalization Rates Drop in First Season With Widespread Preventive Product Use

Brooke McCormick

New respiratory syncytial virus (RSV) prevention products significantly reduce infant hospitalization rates, highlighting the importance of timely vaccination and nirsevimab administration.

February 19th 2025

Nirsevimab, RSVpreF Saw High Uptake With No Preterm Risk for RSVpreF

Pearl Steinzor

High vaccine uptake shows promise for the prevention of respiratory syncytial virus (RSV) in infants.

November 24th 2024

Low RSV Vaccination Rates in Nursing Homes Highlight Urgent Need for Uptake

Pearl Steinzor

Significant gaps in vaccination coverage among nursing home residents leaves vulnerable populations at risk for severe complications, report finds.

November 22nd 2024

In-Room Air Purifiers Could Impact RSV Incidence Among Older Adults

Kennedy Ferruggia

Use of in-room air purifiers with HEPA-14 filters did not result in a significant reduction of acute respiratory infections.

November 20th 2024

Community Pharmacies Hold Key Role in Protecting Older Adults From RSV

Pearl Steinzor

New research reveals gaps in respiratory syncytial virus (RSV) knowledge among older adults and emphasizes the impact community pharmacies can have at improving education and vaccine uptake.

November 15th 2024

RSV Vaccine Proven Effective in Reducing RSV-Related Hospitalizations

Kennedy Ferruggia

Respiratory syncytial virus (RSV) vaccination is approximately 77% to 81% effective against hospital and emergency department encounters among older adults, study finds.

Related Content

Advertisement

May 14th 2025

Infant RSV Hospitalization Rates Drop in First Season With Widespread Preventive Product Use

Brooke McCormick

New respiratory syncytial virus (RSV) prevention products significantly reduce infant hospitalization rates, highlighting the importance of timely vaccination and nirsevimab administration.

February 19th 2025

Nirsevimab, RSVpreF Saw High Uptake With No Preterm Risk for RSVpreF

Pearl Steinzor

High vaccine uptake shows promise for the prevention of respiratory syncytial virus (RSV) in infants.

November 24th 2024

Low RSV Vaccination Rates in Nursing Homes Highlight Urgent Need for Uptake

Pearl Steinzor

Significant gaps in vaccination coverage among nursing home residents leaves vulnerable populations at risk for severe complications, report finds.

November 22nd 2024

In-Room Air Purifiers Could Impact RSV Incidence Among Older Adults

Kennedy Ferruggia

Use of in-room air purifiers with HEPA-14 filters did not result in a significant reduction of acute respiratory infections.

November 20th 2024

Community Pharmacies Hold Key Role in Protecting Older Adults From RSV

Pearl Steinzor

New research reveals gaps in respiratory syncytial virus (RSV) knowledge among older adults and emphasizes the impact community pharmacies can have at improving education and vaccine uptake.

November 15th 2024

RSV Vaccine Proven Effective in Reducing RSV-Related Hospitalizations

Kennedy Ferruggia

Respiratory syncytial virus (RSV) vaccination is approximately 77% to 81% effective against hospital and emergency department encounters among older adults, study finds.